Kari Kendra
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cutaneous Melanoma Detection and Management
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Oncology 71
- Cancer Immunotherapy and Biomarkers 43
- CAR-T cell therapy research 17
- Cutaneous Melanoma Detection and Management 14
-
- Melanoma and MAPK Pathways 25
- Co-authors
- Benita S. Katzenellenbogen (3 shared papers)Yolande Berthois (1 shared paper)William E. Carson (23 shared papers)Gregory B. Lesinski (15 shared papers)Dwight H. Owen (23 shared papers)Michael J. Walker (5 shared papers)Thomas Olencki (22 shared papers)Gregory A. Otterson (20 shared papers)
- Journals
- Journal of Clinical Oncology (34 papers)Cancer Immunology Immunotherapy (9 papers)Annals of Oncology (5 papers)Clinical Cancer Research (4 papers)Journal of Immunotherapy (4 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Kari Kendra
112 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 90
- Oncology 1.3k
- Immunology 497
- Genetics 454
- Molecular Biology 927
- Cancer Research 185
Countries citing papers authored by Kari Kendra
This map shows the geographic impact of Kari Kendra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kari Kendra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kari Kendra more than expected).
Fields of papers citing papers by Kari Kendra
This network shows the impact of papers produced by Kari Kendra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kari Kendra. The network helps show where Kari Kendra may publish in the future.
Co-authors
The 25 scholars most cited alongside Kari Kendra, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 122 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Proliferation, hormonal responsiveness, and estrogen receptor content of MCF-7 human breast cancer cells grown in the short-term and long-term absence of estrogens. | 1987 | 356 |
| 2 | 2019 | 153 | |
| 3 | 2012 | 126 | |
| 4 | 2007 | 118 | |
| 5 | 2004 | 114 | |
| 6 | 2006 | 100 | |
| 7 | 2019 | 84 | |
| 8 | 2021 | 76 | |
| 9 | 2020 | 71 | |
| 10 | 2004 | 60 | |
| 11 | 2003 | 49 | |
| 12 | 2015 | 49 | |
| 13 | 2020 | 46 | |
| 14 | 1987 | 46 | |
| 15 | 2014 | 44 | |
| 16 | 2014 | 41 | |
| 17 | 2017 | 40 | |
| 18 | 2011 | 40 | |
| 19 | 2010 | 38 | |
| 20 | 1999 | 38 |
About Kari Kendra
Kari Kendra is a scholar working on Oncology, Molecular Biology, Immunology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 122 papers that have together received 2.6k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (43 papers), Melanoma and MAPK Pathways (25 papers), CAR-T cell therapy research (17 papers), Cutaneous Melanoma Detection and Management (14 papers), Immunotherapy and Immune Responses (9 papers), Brain Metastases and Treatment (7 papers), Lung Cancer Treatments and Mutations (7 papers) and Immune cells in cancer (6 papers). The work is most often cited by research in Oncology (1.3k citations), Immunology (497 citations), Genetics (454 citations), Molecular Biology (927 citations) and Cancer Research (185 citations). Kari Kendra has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Benita S. Katzenellenbogen, Yolande Berthois, William E. Carson, Gregory B. Lesinski, Dwight H. Owen, Michael J. Walker, Thomas Olencki, Gregory A. Otterson, Helen X. Chen and Dimosthenis Mantopoulos. Their work appears in journals such as Journal of Clinical Oncology, Cancer Immunology Immunotherapy, Annals of Oncology, Clinical Cancer Research and Journal of Immunotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.